Read + Share
Amedeo Smart
Independent Medical Education
Zeng Z, Ly C, Daver N, Cortes J, et al. High-throughput proteomic profiling reveals mechanisms of action of AMG925, a dual FLT3-CDK4/6 kinase inhibitor targeting AML and AML stem/progenitor cells. Ann Hematol 2021;100:1485-1496.PMID: 33787984
Email
LinkedIn
Facebook
Twitter
Privacy Policy